Member Info for Chelsea11

I’ve just pinged Thomas Moore an email referencing his article of 14/02 and simply pointing him towards official news flow. No doubt the Scancell PR machine has already done, or soon will do, the same thing but I didn’t thing it could do any harm. I’m not expecting a response but will let you know if it’s acknowledged.

I make it 18 to this point, since the Sky article :-)

And Scancell Tweet...........

Wonder what sort of timeframe is wrapped around this element?

A regulatory application to initiate a Phase 1 clinical trial of COVIDITY has been submitted to the South African Health Products Regulatory Authority (SAHPRA).

Was confirmed in the last Trading Update:

The Board will provide a further update on trading and prospects in mid-July 2021

Surprisingly steep drop in the SP today, particularly given the rest of the Industrial Transportation sector seems ok. No RNS to this point either.

Hopefully support will come in and the SP will recover through this week.

Jerry Randall, CEO commented: "I am delighted to announce the completion of this facility, as I had indicated was expected in our announcement of the acquisition of BBI Healthcare on 7th June 2021. This facility will significantly extend the reach of the cash we raised from shareholders in December 2020, leveraging the cashflows of the existing business and providing firepower for future acquisitions. As a profitable and cash generative business, it is key to our successful growth that we make use of this low-cost, non-dilutive funding at sensible levels, to both supplement shareholder support and minimise dilution. Interest rates remain at a low level and debt provides an efficient method to provide some of the funding for our growth.



We have been working with Santander, our main bank in the UK, and Silicon Valley Bank for some time to put this facility in place, and I am very pleased with the facilities now available and the support provided by both banks in getting to this point. I am sure this will be a long and fruitful partnership, and I would like to take this opportunity to thank Santander, Silicon Valley Bank and my colleagues internally for doing an excellent job in completing this facility. I am also delighted to have such blue-chip names supporting the growth of the business, which is a significant validation or our model, our vision and our team.

Hard luck today TF. Heartbreaking way to lose. Maybe a stellar RNS next week will be some consolation......

Well after today, just 8 trading days until the end of the much fabled H1. Maybe as an alternative to Tick-Tock we could have a Scancell BB rendition of Oranges and Lemons. Much of it seems very apt in present circumstances!

Oranges and lemons,
Say the bells of St. Clement's.

You owe me five farthings,
Say the bells of St. Martin's.

When will you pay me?
Say the bells at Old Bailey.

When I grow rich,
Say the bells at Shoreditch.

When will that be?
Say the bells of Stepney.

I do not know,
Says the great bell at Bow.

Here comes a candle to light you to bed,
And here comes a chopper to chop off your head!
Chip chop chip chop the last man is dead

HAGW all
C11

BBC2 9pm tonight might be interesting.

HAGE all.

Level 2 and Fire almost in the same post there :-)

Tick-up on US opening maybe?

From 07/06:

The Company continues to progress the Modi-1 Phase 1/2 clinical trial for regulatory submission to start the planned clinical study in the UK in the first half of 2021.

Today:

The Company continues to progress the Modi-1 Phase 1/2 clinical trial for regulatory submission in the first half of 2021.

Agree with your post Ports. I’m expecting the July update to be positive, reasonable expectation I believe, given all updates seen to date this year. Exactly how positive is of course an unknown until we reach that point in time but still a fair chance I believe, of seeing the SP push into the low 40s in Q3. Directors will be pulling out stops to make that happen inside the next 6 months given their incentive package.

Great read Wild and it made me go back to the article published in the Independent - actually less than 1 month ago:

In the UK, scientists from the University of Nottingham and a company called Scancell are working to develop an mRNA-based jab specific to all Covid variants. Their vaccine targets the conserved core of SarsCoV-2, called the nucleocapsid, as well as the spike protein, which is the main site of the mutations that have been detected to date.
Dr Gillies O’Bryan-Tear, Scancell chief medical officer, told The Independent: “What’s been mutating in the pandemic has been the spike protein, which alters the transmissibility of the virus and can alter its ability to resist either the immunity acquired by natural infection or vaccination.
“The difference between our technology and most others is that as well as targeting the spike protein, we have another specificity in our vaccine which targets the nucleocapsid protein. This is the body of the virus. We don’t think it mutates as much as the spike does, so there’s a chance it could work across different variants irrespective of the spike protein mutations.”
Human trials of the vaccine will begin in the second half of this year after testing on mice returned positive results.

I know we all read this but refreshing how closely aligned both articles are. Surely, surely we are in CEPI’s thoughts.......

HAGW all. Enjoy the sun if it’s shining where you are.

https://news.sky.com/story/covid-19-delta-variant-60-more-transmissible-than-alpha-and-more-resistant-to-vaccines-phe-reports-12330068

Investor Presentation (see latest RNS) now up on the EKF website.https://www.ekfdiagnostics.com/res/EKF%20Investor%20Presentation%20June%202021%20Growth%20strategy%202021-2024.pdf

Still no “correction” to the Modi-1 section of the Director Dealing RNS then. Not hanging my hat on that but would have considered as price-sensitive information.

Sun still shining. Scancell’s time to burn as brightly and for the rest of the Summer. Dollops of Factor 30 required, sunglasses on and maybe have to dig out the t-shirt if the mercury rises too high :-)

Hi Ports. I believe you’re correct in that the role relates to new depots / premises. However whilst advertised as based in Leeds, the job spec confirms travel all over the UK. Perhaps the most telling sentence is - “ Surveying proposed new sites and producing site plans which fulfil operational requirements and are fully compliant with all current legislation”. We know new depots are coming and it wouldn’t surprise me to hear news in that space ahead of July financials.

Empty I should imagine Ray!

Ray,

Errrrrrr no!

Maybe that gives some insight into my holding, my lifestyle, or even both!

Have a good evening.